May 31 (Reuters) - Novan Inc :
* NOVAN FOCUSES STRATEGIC DIRECTION AND ANNOUNCES RESTRUCTURING
* NOVAN INC - DIRECTING RESOURCES ON POTENTIAL APPROVAL OF BERDAZIMER GEL, 10.3% (SB206) FOR MOLLUSCUM CONTAGIOSUM
* NOVAN INC - PROCESS TO EXPLORE A SALE OR OUT-LICENSE OF COMMERCIAL ASSETS OR OTHER BUSINESS TRANSACTION CONTINUES
* NOVAN INC - CONTINUED PROGRESS TOWARD PDUFA GOAL DATE OF JANUARY 5, 2024, FOR BERDAZIMER GEL, 10.3%
* NOVAN INC - CONTINUED PROGRESS TOWARD PDUFA GOAL DATE OF JANUARY 5, 2024, FOR BERDAZIMER GEL, 10.3%
* NOVAN INC - WILL IMMEDIATELY REDUCE CERTAIN OF ITS OPERATING EXPENSES CURRENTLY SUPPORTING ITS COMMERCIAL OPERATIONS.
* NOVAN - TO SELL AND DISTRIBUTE COMMERCIAL PRODUCTS, INCUR CERTAIN RELATED EXPENSES ASSOCIATED WITH RHOFADE, WYNZORA, MINOLIRA, CLODERM IN U.S.
* NOVAN - EXISTING CASH AND CASH EQUIVALENTS AS OF MARCH 31 TO PROVIDE CO WITH LIQUIDITY TO FUND PLANNED OPERATIONS INTO LATE JUNE
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。